Thursday, July 9, 2026 Every July, a wave of federal benefit payments resets for the new benefit year — and 2026 brings one of the biggest shifts in years. Between a permanent 25% boost to the old GST/HST credit, a fresh Canada Child Benefit increase, and the largest quarterly OAS bump of the year, millions of Canadian households will see different numbers land in their accounts this month. Here's what actually changed, and what to check in your own CRA account. The GST/HST Credit Has a New Name — and a Bigger Payout The GST/HST credit has officially been replaced by the Canada Groceries and Essentials Benefit (CGEB) . It's not a new program from scratch — it runs on the same CRA infrastructure and eligibility rules — but the payment amounts are 25% higher, and that increase is locked in for five years. The first CGEB payment went out on July 3, 2026. Under the new structure: A single individual with no children can receive up to roughly $679 per year (about $170 per quart...
Market Swings and Sector Trends: Stock Update for August 4, 2023
Navigating Volatility
On August 4, 2023, the stock market experienced a mixed and volatile day of trading. Several major indices opened with slight gains, but the momentum did not sustain throughout the session. Technology stocks faced a significant downturn, largely due to concerns over increasing regulatory scrutiny and the ongoing global semiconductor shortage.
Companies in the energy sector, on the other hand, witnessed a modest increase in their stock prices as oil prices edged higher amid geopolitical tensions in key oil-producing regions. The financial sector showed resilience, with banking stocks posting gains after positive earnings reports from major financial institutions.
Overall, the day's trading activity highlighted the ongoing uncertainties in the market, with investors closely monitoring economic indicators and corporate earnings reports for potential signals of future trends.
Sector Shifts and Market Fluctuations
In the middle of the broader market fluctuations, some individual stocks stood out with remarkable performances. A tech startup in the electric vehicle industry experienced a remarkable surge in its share price following news of securing a major partnership with an established automaker.
Conversely, a pharmaceutical giant faced a notable decline in its stock value due to disappointing results in a late-stage clinical trial for a highly anticipated drug. Investors continued to grapple with macroeconomic challenges, including the impact of the ongoing global supply chain disruptions and the persisting effects of the COVID-19 pandemic on various sectors.
As the trading day concluded, market participants remained cautious, and analysts emphasized the importance of staying vigilant and well-informed in the ever-changing landscape of the financial markets.
Comments
Post a Comment